Clinical Trials Directory

Trials / Completed

CompletedNCT06251882

Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia

6-month Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Meralgia paresthetica (MP) is one of the most common peripheral entrapment neuropathies of the lower limbs. It is characterized by paresthesia, pain, tingling, numbness, hypersensitivity, or other abnormal skin sensations on the anterolateral aspect of the thigh. The condition results from compression of the lateral femoral cutaneous nerve (LFCN) along its course, often occurring as the nerve exits the pelvis.The injection of 5% dextrose (D5W) under ultrasound guidance is a novel treatment method for peripheral nerve entrapment. However, there is limited evidence about the efficacy of this method for patients with MP. The investigators found D5W was more safe and effective than corticosteroids for patients with MP. Thus, this study aimed to evaluate the 6-month efficacy of ultrasound-guided injection of D5W for MP patients.

Conditions

Interventions

TypeNameDescription
OTHERinjection10ml D5W injection for MP patients

Timeline

Start date
2022-01-01
Primary completion
2023-06-30
Completion
2024-01-30
First posted
2024-02-09
Last updated
2024-02-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06251882. Inclusion in this directory is not an endorsement.